<DOC>
	<DOCNO>NCT02096328</DOCNO>
	<brief_summary>To investigate pharmacokinetic characteristic POL7080 co-administered SoC 10 14 day treatment VAP patient due suspect documented Pseudomonas aeruginosa infection</brief_summary>
	<brief_title>Pharmacokinetics , Safety Efficacy POL7080 Patients With Ventilator Associated Pseudomonas Aeruginosa Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Ventilator-Associated</mesh_term>
	<mesh_term>Pseudomonas Infections</mesh_term>
	<mesh_term>Respiratory Tract Infections</mesh_term>
	<criteria>1 . Male female patient â‰¥18 year age diagnose VAP , i.e. , pneumonia arise 96 hour endotracheal intubation document suspect due Pseudomonas aeruginosa 2 . Respiratory specimen suitable culture Gram stain collect start treatment 3 . Written Informed consent patient 's legally acceptable representative relative 1 . Patients know hypersensitivity fluoroquinolones , carbapenems , cephalosporin , penicillin ( betalactam antibiotic ) aminoglycoside antibiotic ( i.e . available SoC antibiotic ) ; patient clinically significant history drug allergy history anaphylactic reaction patient active allergic condition time screen 2 . Known suspected pulmonary condition likely interfere therapeutic response might additional impact pharmacokinetics 3 . Patients Acute Physiology Chronic Health Evaluation II ( APACHE II ) score &gt; 25 4 . Presence septic shock time evaluation study entry 5 . History lung transplant 6 . Patients know HIV infection CD4+ ( cluster differentiation 4 ) cell count &lt; 200/mm3 7 . Concomitant morbidity severity patient likely die present serious medical condition within 7 day study entry 8 . Patients impaired renal function 9 . Patients currently enrol , yet complete least 30 day since end another investigational device drug trial receive investigational agent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Ventilator Associated Pneumonia ( VAP )</keyword>
	<keyword>Lower respiratory infection</keyword>
	<keyword>POL7080</keyword>
	<keyword>Pseudomonas aeruginosa</keyword>
	<keyword>Nosocomial pneumonia</keyword>
</DOC>